Avadel Pharmaceuticals PLC - ADR

1
NAS:AVDL (Ireland)   ADR
$ 15.78 -0.15 (-0.94%) 11:08 PM EST
At Loss
P/B:
16.17
Volume:
519.71K
Avg Vol (2M):
1.43M
Also Trade In:
Volume:
519.71K
At Loss
Avg Vol (2M):
1.43M

Business Description

Avadel Pharmaceuticals PLC
NAICS : 325414 SIC : 2834
ISIN : US05337M1045

Share Class Description:

AVDL: ADR
Description
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
Name Current Vs Industry Vs History
Cash-To-Debt 40.06
Equity-to-Asset 0.53
Debt-to-Equity 0.03
Debt-to-EBITDA -0.02
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.66
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 51.64
9-Day RSI 58.93
14-Day RSI 58.64
6-1 Month Momentum % 14.51
12-1 Month Momentum % 52.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.64
Quick Ratio 3.36
Cash Ratio 2.85
Days Inventory 2459.94
Days Sales Outstanding 87.53
Days Payable 4693.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.4
Shareholder Yield % -3.45

Financials (Next Earnings Date:2024-04-04)

AVDL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AVDL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Avadel Pharmaceuticals PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 27.963
EPS (TTM) ($) -2.01
Beta 1.88
Volatility % 59.57
14-Day RSI 58.64
14-Day ATR ($) 0.81377
20-Day SMA ($) 14.63025
12-1 Month Momentum % 52.3
52-Week Range ($) 8 - 17.24
Shares Outstanding (Mil) 90.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Avadel Pharmaceuticals PLC Filings

Filing Date Document Date Form
No Filing Data

Avadel Pharmaceuticals PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Avadel Pharmaceuticals PLC Frequently Asked Questions

What is Avadel Pharmaceuticals PLC(AVDL)'s stock price today?
The current price of AVDL is $15.78. The 52 week high of AVDL is $17.24 and 52 week low is $8.00.
When is next earnings date of Avadel Pharmaceuticals PLC(AVDL)?
The next earnings date of Avadel Pharmaceuticals PLC(AVDL) is 2024-04-04.
Does Avadel Pharmaceuticals PLC(AVDL) pay dividends? If so, how much?
Avadel Pharmaceuticals PLC(AVDL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1